Free Trial

The Cigna Group (CI) Stock Forecast & Price Target

The Cigna Group logo
$311.33 -0.85 (-0.27%)
Closing price 06/9/2025 03:59 PM Eastern
Extended Trading
$312.50 +1.17 (+0.37%)
As of 07:08 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

The Cigna Group - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
0
Hold
2
Buy
17

Based on 19 Wall Street analysts who have issued ratings for The Cigna Group in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 19 analysts, 2 have given a hold rating, 16 have given a buy rating, and 1 has given a strong buy rating for CI.

Consensus Price Target

$380.39
22.18% Upside
According to the 19 analysts' twelve-month price targets for The Cigna Group, the average price target is $380.39. The highest price target for CI is $438.00, while the lowest price target for CI is $323.00. The average price target represents a forecasted upside of 22.18% from the current price of $311.33.
Get the Latest News and Ratings for CI and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for The Cigna Group and its competitors.

Sign Up

CI Analyst Ratings Over Time

TypeCurrent Forecast
6/10/24 to 6/10/25
1 Month Ago
5/11/24 to 5/11/25
3 Months Ago
3/12/24 to 3/12/25
1 Year Ago
6/11/23 to 6/10/24
Strong Buy
1 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
2 Strong Buy rating(s)
Buy
16 Buy rating(s)
16 Buy rating(s)
13 Buy rating(s)
12 Buy rating(s)
Hold
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$380.39$378.22$372.31$373.87
Forecasted Upside22.18% Upside13.31% Upside19.68% Upside10.33% Upside
Consensus Rating
Moderate Buy
Buy
Buy
Buy

CI Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

CI Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

The Cigna Group Stock vs. The Competition

TypeThe Cigna GroupMedical CompaniesS&P 500
Consensus Rating Score
2.95
2.81
2.53
Consensus RatingModerate BuyModerate BuyModerate Buy
Predicted Upside22.18% Upside5,918.80% Upside13.46% Upside
News Sentiment Rating
Positive News

See Recent CI News
Positive News
Positive News
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
6/3/2025Royal Bank of Canada
3 of 5 stars
Ben Hendrix
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$371.00+19.41%
6/2/2025Barclays
3 of 5 stars
Andrew Mok
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$382.00 ➝ $385.00+22.49%
5/23/2025Guggenheim
2 of 5 stars
J. Cassorla
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$388.00+24.15%
5/12/2025Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
David Macdonald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetBuy ➝ Buy$385.00 ➝ $405.00+29.08%
5/5/2025Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingBuy ➝ Buy
5/5/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jessica Tassan
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$348.00 ➝ $374.00+12.09%
5/5/2025Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Erin Wright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$379.00 ➝ $390.00+16.04%
4/15/2025Robert W. Baird
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$388.00 ➝ $362.00+10.13%
4/9/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOutperform ➝ Outperform$360.00 ➝ $384.00+22.66%
3/20/2025Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Sarah James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$350.00 ➝ $365.00+13.53%
2/6/2025Sanford C. Bernstein
Subscribe to MarketBeat All Access for the recommendation accuracy rating
L. Wilkes
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform$323.00+10.24%
2/4/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Stephen Baxter
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetEqual Weight ➝ Equal Weight$370.00 ➝ $341.00+16.46%
2/3/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Kevin Caliendo
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetBuy ➝ Buy$410.00 ➝ $390.00+31.64%
1/31/2025Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
John Ransom
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingStrong-Buy ➝ Strong-Buy$415.00 ➝ $360.00+21.26%
1/31/2025Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Michael Wiederhorn
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOutperform ➝ Outperform$400.00 ➝ $375.00+26.31%
1/31/2025Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Raj Kumar
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower TargetOverweight ➝ Overweight$410.00 ➝ $380.00+28.89%
11/4/2024Deutsche Bank Aktiengesellschaft
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy ➝ Buy$398.00 ➝ $394.00+25.93%
9/17/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$402.00 ➝ $422.00+16.25%
8/21/2024JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight ➝ Overweight$435.00 ➝ $438.00+27.49%
5/30/2024Baird R W
Subscribe to MarketBeat All Access for the recommendation accuracy rating
M. Ha
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
8/17/2023Edward Jones
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeBuy ➝ Hold
8/4/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$320.00 ➝ $350.00+21.48%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 07:10 AM ET.


Should I Buy The Cigna Group Stock? CI Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, June 7, 2025. Please send any questions or comments about these The Cigna Group pros and cons to contact@marketbeat.com.

The Cigna Group
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in The Cigna Group:

  • The Cigna Group recently reported strong quarterly earnings, exceeding analysts' expectations with earnings per share significantly higher than consensus estimates, indicating robust financial performance.
  • The current stock price is around $311, reflecting a solid market position and potential for growth, especially given the company's recent revenue increase of over 14% year-over-year.
  • The company has a healthy return on equity of 18.61%, suggesting effective management and profitability, which can be attractive to investors looking for strong financial metrics.
  • The Cigna Group has a consistent dividend payout, with a recent quarterly dividend of $1.51 per share, providing a reliable income stream for investors.
  • Institutional ownership is high at approximately 86.99%, indicating confidence from large investors in the company's future prospects.

The Cigna Group
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in The Cigna Group for these reasons:

  • The stock has experienced fluctuations, with a 12-month high of $370.83 and a low of $262.03, which may indicate volatility and risk for potential investors.
  • Insider selling has occurred, with a director recently selling a significant number of shares, which could raise concerns about the company's future outlook from those within the organization.
  • The net margin is relatively low at 1.39%, suggesting that while the company generates substantial revenue, profitability may be constrained, which could affect long-term growth.
  • Market conditions and regulatory changes in the health services sector can impact The Cigna Group's operations and profitability, introducing uncertainty for investors.
  • Despite recent growth, the competitive landscape in the health services industry is intense, which may pose challenges for maintaining market share and profitability.

CI Forecast - Frequently Asked Questions

According to the research reports of 19 Wall Street equities research analysts, the average twelve-month stock price forecast for The Cigna Group is $380.39, with a high forecast of $438.00 and a low forecast of $323.00.

19 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for The Cigna Group in the last year. There are currently 2 hold ratings, 16 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "moderate buy" CI shares.

According to analysts, The Cigna Group's stock has a predicted upside of 22.18% based on their 12-month stock forecasts.

The Cigna Group has been rated by research analysts at Barclays, Cantor Fitzgerald, Cowen, Guggenheim, Mizuho, Morgan Stanley, Piper Sandler, Robert W. Baird, Royal Bank of Canada, and Truist Financial in the past 90 days.

Analysts like The Cigna Group more than other "medical" companies. The consensus rating score for The Cigna Group is 2.95 while the average consensus rating score for "medical" companies is 2.81. Learn more on how CI compares to other companies.


This page (NYSE:CI) was last updated on 6/10/2025 by MarketBeat.com Staff
From Our Partners